Clinical trials: Vitreo-retinal Surgery
Vitreo-Retinal Surgery
DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery
The purpose of this study is to evaluate efficacy and safety of Dextenza for the treatment of postoperative pain and inflammation following vitreo-retinal surgery
- Trial name
- NCT04462523
- Testing
- Dextenza 0.4Mg Ophthalmic Insert, Topical Prednisolone
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Patrick R. Oellers, MD
Vitreo-retinal Surgery
A Phase I Study of Vitargus® in Vitrectomy
A Phase I, safety and tolerability study of Vitargus® in vitrectomy surgery
- Trial name
- NCT04481386
- Testing
- Vitargus, BFC-1401
- Where
- Australia
- Volunteers
- 11 people
- Sponsor
- BioFirst Corporation
Development of Ptosis After Vitreo-retinal Surgery
Preoperative and Intraoperative Factors Related to the Development of Ptosis After Retinal Surgery
The purpose of this study to is to determine the incidence of post-operative ptosis in patients undergoing vitreoretinal surgery.
- Trial name
- NCT01752478
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- University of California, San Francisco